en

PRODUCT DETAIL

Lortanda 2,5 mg filmom obalené tablety

Code 4005A
MA number 44/0029/13-S
Product Form: tbl flm 10x2,5 mg (blis.PVC/PVdC/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BG Enzyme inhibitors
L02BG04 Letrozole
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 31.01.2013
PIL: PIL_Lortanda 25 mg_01/2020.doc.doc  
SPC: SPC_Lortanda 25 mg_01/2020.doc.doc  
Safety feature Yes
Data update: 25.01.2018
eu-flag.png sk-flag.png